Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Renal Dialysis | 3 | 2021 | 4358 | 0.37 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.25 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Anti-Glomerular Basement Membrane Disease | 1 | 2020 | 31 | 0.21 | Why? |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2021 | 235 | 0.17 | Why? |
| Hepcidins | 1 | 2017 | 97 | 0.16 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.16 | Why? |
| Erythropoietin | 1 | 2017 | 167 | 0.15 | Why? |
| Hodgkin Disease | 1 | 2018 | 204 | 0.14 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.12 | Why? |
| Immunoglobulins | 1 | 2018 | 811 | 0.12 | Why? |
| Microfilament Proteins | 1 | 2010 | 45 | 0.11 | Why? |
| Biomarkers, Tumor | 2 | 2018 | 1314 | 0.11 | Why? |
| Kidney Transplantation | 2 | 2021 | 5397 | 0.10 | Why? |
| Anemia | 1 | 2017 | 789 | 0.10 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.10 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.09 | Why? |
| Membrane Glycoproteins | 1 | 2018 | 2273 | 0.09 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.09 | Why? |
| Immunosuppressive Agents | 3 | 2021 | 6331 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.09 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.08 | Why? |
| Carrier Proteins | 1 | 2010 | 513 | 0.08 | Why? |
| Colonic Neoplasms | 1 | 2010 | 295 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.07 | Why? |
| Lymph Nodes | 1 | 2010 | 1060 | 0.06 | Why? |
| Adenocarcinoma | 1 | 2010 | 651 | 0.06 | Why? |
| Glomerular Basement Membrane | 1 | 2020 | 17 | 0.05 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2021 | 325 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Aged | 9 | 2021 | 215776 | 0.04 | Why? |
| Metabolic Clearance Rate | 1 | 2017 | 110 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Salvage Therapy | 1 | 2018 | 417 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| London | 1 | 2020 | 2166 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Humans | 11 | 2021 | 930598 | 0.03 | Why? |
| Iron | 1 | 2017 | 619 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2010 | 393 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Immunoenzyme Techniques | 1 | 2010 | 448 | 0.02 | Why? |
| Lymphatic Metastasis | 1 | 2010 | 537 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Colon | 1 | 2010 | 669 | 0.02 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2010 | 4260 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Australia | 1 | 2010 | 6306 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Survival Rate | 1 | 2010 | 9206 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.00 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.00 | Why? |
| Prognosis | 1 | 2010 | 32490 | 0.00 | Why? |